Entrada Therapeutics Inc (TRDA) — Working Capital to Net Assets Ratio

Latest as of June 2026: 90.5%

Entrada Therapeutics Inc (TRDA) has a Working Capital to Net Assets ratio of 90.5% as of June 2026. Working capital of $211.33 Million (current assets of $232.70 Million minus current liabilities of $21.37 Million) is measured against net assets of $233.41 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.

WC/NA Ratio

90.5%
Working Capital / Net Assets

Working Capital

$211.33 Million
USD

Current Assets

$232.70 Million
USD

Current Liabilities

$21.37 Million
USD

Entrada Therapeutics Inc Working Capital to Net Assets (2019–2025)

This chart shows how Entrada Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 90.5%, reflecting working capital of $211.33 Million against net assets of $233.41 Million USD. See TRDA cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Annual Working Capital to Net Assets for Entrada Therapeutics Inc (2019–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Entrada Therapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TRDA total asset value.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 92.1% $281.80 Million $306.13 Million $306.25 Million $24.45 Million ▼ -1.4 pp
2024 93.4% $400.56 Million $428.68 Million $440.04 Million $39.48 Million ▲ +6.4 pp
2023 87.1% $210.97 Million $242.36 Million $369.77 Million $158.80 Million ▼ -1.4 pp
2022 88.4% $187.90 Million $212.55 Million $209.88 Million $21.97 Million ▼ -9.3 pp
2021 97.7% $291.98 Million $298.72 Million $298.70 Million $6.72 Million ▲ +185.9 pp
2020 -88.2% $36.59 Million $-41.49 Million $39.95 Million $3.36 Million ▲ +11.8 pp
2019 -100.0% $15.52 Million $-15.52 Million $17.44 Million $1.92 Million —
pp = percentage points